Download - Molecular characteristics of HIV-2
![Page 1: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/1.jpg)
Molecular characteristics of HIV-2
Frank Kirchhoff Institute of Molecular VirologyUlm Medical Center, Germany
7/11
![Page 2: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/2.jpg)
HIV-2: Origin
Non-pathogenicHigh VLs
Highlypathogenic
ModeratelyPathogenic
80% LTNPs, lowVLs
Only HIV-2 groups A and B have spread significantly in humans
![Page 3: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/3.jpg)
• Vpx: antagonizes SAMHD1 (Laguette et al., 2011; Hrecka et al., 2011) • No Vpu: CD4 degradation and tetherin antagonism in HIV-1• Nef: effective down-modulation of TCR-CD3 and CD28
HIV-2: molecular characteristics
![Page 4: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/4.jpg)
HIV-2: absence of Vpu
Perez-Caballero et al., 2009
• HIV-1 M strains use Vpu to antagonize tetherin• HIV-2 A uses Env• Unclear whether HIV-2 B-H counteract tetherin
![Page 5: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/5.jpg)
Nef, Vpu Nef, EnvNef
HIV-2: absence of Vpu
Perez-Caballero et al., 2009
• HIV-1 M strains use Vpu to antagonize tetherin• HIV-2 A uses Env• Unclear whether HIV-2 B-H counteract tetherin
![Page 6: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/6.jpg)
Nef, Vpu Nef, EnvNef
HIV-2: absence of Vpu
Perez-Caballero et al., 2009
• HIV-1 M strains use Vpu to antagonize tetherin• HIV-2 A uses Env• Unclear whether HIV-2 B-H counteract tetherin
???
![Page 7: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/7.jpg)
Nef, Vpu Nef, EnvNef
HIV-2: absence of Vpu
Perez-Caballero et al., 2009
• HIV-1 M strains use Vpu to antagonize tetherin• HIV-2 A uses Env• Unclear whether HIV-2 B-H counteract tetherin
![Page 8: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/8.jpg)
HIV-2: effective Nef-mediated down-modulation of TCR-CD3 and CD28
![Page 9: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/9.jpg)
HIV-1 SIVcpz
CD3
SIVsmmHIV-2
CD3
chronic activationdeath of T cellsAIDS
little activationT cells survivetolerance
Antigenpresenting cell Resting T cellAntigenpresenting cell Activated T cellActivation induced
cell death
Antigenpresenting cell Resting T cellAntigenpresenting cell “Resting“ T cell Antigenpresenting cell “Resting“ T cell
Infected PBMC
HIV-2: effective Nef-mediated down-modulation of TCR-CD3 and CD28
![Page 10: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/10.jpg)
Disruption of the immune synapse between vially infected T cells and APCs (Arhel et al., J. Clin. Invest. 2009)
HIV-2 prevents the interaction between T cells and APCs, whereas HIV-1 just deregulates it
HIV-2: effective Nef-mediated down-modulation of TCR-CD3 and CD28
![Page 11: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/11.jpg)
Inefficient Nef-mediated downmodulation of CD3 correlates with loss of CD4+T cells in natural SIV infection (Schindler et al. PLOS Path. 2008)
Nef may protect the natural hosts of SIV against the loss of CD4+ T cells by down-modulation of TCR-CD3 to prevent activation-induced cell death
![Page 12: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/12.jpg)
Downregulation of CD3 by HIV-2 Nef does not protect against disease (Feldmann et al., JVI 2009) BUT Most HIV-2-infected individuals had low VLs and high CD4+ T cell counts and the nef alleles were only examined using expression constructs in Jurkat T cells The efficiency of TCR-CD3 downregulation by Nef correlated with low levels of immune activation in vivo
![Page 13: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/13.jpg)
Downregulation of CD3 by HIV-2 Nef does not protect against disease (Feldmann et al., JVI 2009) BUT Most HIV-2-infected individuals had low VLs and high CD4+ T cell counts and the nef alleles were only examined using expression constructs in Jurkat T cells The efficiency of TCR-CD3 downregulation by Nef correlated with low levels of immune activation in vivo
![Page 14: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/14.jpg)
Downregulation of CD3 by HIV-2 Nef does not protect against disease (Feldmann et al., JVI 2009) BUT Most HIV-2-infected individuals had low VLs and high CD4+ T cell counts and the nef alleles were only examined using expression constructs in Jurkat T cells The efficiency of TCR-CD3 downregulation by Nef correlated with low levels of immune activation in vivo
Analysis of nef alleles from 20 viremic (VL >500/ml) and 16 non-viremic (<500/ml) HIV-2-infected individuals (Feldmann et al., 2009; Guillon et al., 1998; Blaak et al., 2008)
![Page 15: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/15.jpg)
Nef-mediated downmodulation of TCR-CD3 correlates with high numbers of CD4+ T cells in viremic HIV-2-infected individuals
All Non-viremic Viremic
![Page 16: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/16.jpg)
All Non-viremic Viremic
Nef-mediated downmodulation of CD28 correlates with high numbers of CD4+ T cells in viremic HIV-2-infected individuals
Other Nef functions (modulation of CD4 & MHC-I, enhancement of infectivity & replication) did not correlate with the CD4+ T cell counts in infected individuals
![Page 17: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/17.jpg)
T cells infected with viruses containing HIV-2 nef genes express low levels of death receptors and activation markers
![Page 18: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/18.jpg)
PBMC cultures infected with viruses containing HIV-2 nef genes express low levels of type I interferons
![Page 19: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/19.jpg)
• Effective infection of MPs and DCs by Vpx-mediated degradation of SAMHD1• Antagonism of human tetherin by the Envelope glycoprotein (HIV-2 group A; B-H unclear)• Potent suppression of T cell activation by Nef-mediated down-modulation of TCR-CD3 & CD28
Characteristics of HIV-2: Summary
(Preliminary) conclusions
• Tetherin antagonism may play a role in the spread of HIV-2
• Nef may help viremic HIV-2-infected individuals to maintain normal CD4+ T cell counts by preventing T cell activation & apoptosis
![Page 20: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/20.jpg)
• Effective infection of MPs and DCs by Vpx-mediated degradation of SAMHD1• Antagonism of human tetherin by the Envelope glycoprotein (HIV-2 group A; B-H unclear)• Potent suppression of T cell activation by Nef-mediated down-modulation of TCR-CD3 & CD28
Characteristics of HIV-2: Summary
(Preliminary) conclusions
• Tetherin antagonism may play a role in the spread of HIV-2
• Nef may help viremic HIV-2-infected individuals to maintain normal CD4+ T cell counts by preventing T cell activation & apoptosis
![Page 21: Molecular characteristics of HIV-2](https://reader035.vdocuments.us/reader035/viewer/2022062812/56816450550346895dd618bb/html5/thumbnails/21.jpg)
Efficient Nef-mediated downmodulation of TCR-CD3 is associated with high CD4+ T cell counts in viremic HIV-2-infected individuals
Mohammad Khalid,1 Jerome Feldman,2 Rob A. Gruters,3 Hetty Blaak,3 Marchina E. van der Ende,4 Sarah Rowland-Jones,5,6
Albert D. Osterhaus,3 and Frank Kirchhoff1
1Institute of Molecular Virology, University Clinic Ulm, Germany; 2Unité Virus et Immunité, Institut Pasteur, Paris, France; 3Dep. of Virology and 4 Dep. of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; 5MRC Laboratories, Fajara, The Gambia; 6MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Deutsche Forschungsgemeinschaft